Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Epidemics
|
May 22, 2026
From survey to solutions: Tackling diversity and inclusion gaps through an inclusion task force
Ruthie Birger, Arthur Schurr, Dustin G Padilla, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
August 20, 2020
Combined Tumor Environment Triggered Self-Assembling Peptide Nanofibers and Inducible Multivalent Ligand Display for Cancer Cell Targeting with Enhanced Sensitivity and Specificity
Weike Chen, Shuxin Li, John C Lang, et al.
Vaccines
|
May 26, 2026
Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United States
Klodeta Kura, John C Lang, Dawei Wang, et al.
Journal of Chromatography. A
|
March 17, 2015
Separation of therapeutic peptides with cyclofructan and glycopeptide based columns in hydrophilic interaction liquid chromatography
Yang Shu, John C Lang, Zachary S Breitbach, et al.
Epidemics
|
July 9, 2026
Clinical impact of childhood and adolescence dengue vaccination in Indonesia: A dynamic transmission modeling study
Salisu M Garba, Ibrahim Diakite, Yao-Hsuan Chen, et al.
Journal of Agricultural and Food Chemistry
|
February 9, 2016
Analysis of Long-Chain Unsaturated Fatty Acids by Ionic Liquid Gas Chromatography
Choyce A Weatherly, Ying Zhang, Jonathan P Smuts, et al.
Vaccines
|
June 27, 2025
Predicting the Epidemiological Effects in the United Kingdom of Moving from PCV13 to PCV15 in the Routine Pediatric 1 + 1 Vaccination Schedule
Rachel J Oidtman, Natalie Banniettis, Jessica Weaver, et al.
Expert Review of Vaccines
|
May 22, 2026
Epidemiological impact of a 20- or 21-valent pneumococcal conjugate vaccine in the Japan adult population: insights from a dynamic transmission model
Rachel J Oidtman, Atsushi Tajima, Taizo Matsuki, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
July 9, 2026
Health impact and cost-effectiveness analysis of introducing a national immunization program with 21-valent versus 20-valent pneumococcal conjugate vaccines for adults ≥ 65 years of age in Denmark
Oluwaseun Sharomi, Rachel J Oidtman, John C Lang, et al.
Journal of Preventive Medicine and Hygiene
|
April 20, 2026
Giovanna Elisa Calabrò, Caterina Rizzo, Vincenzo Baldo, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Epidemics
|
May 22, 2026
From survey to solutions: Tackling diversity and inclusion gaps through an inclusion task force
Ruthie Birger, Arthur Schurr, Dustin G Padilla, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
August 20, 2020
Combined Tumor Environment Triggered Self-Assembling Peptide Nanofibers and Inducible Multivalent Ligand Display for Cancer Cell Targeting with Enhanced Sensitivity and Specificity
Weike Chen, Shuxin Li, John C Lang, et al.
Vaccines
|
May 26, 2026
Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United States
Klodeta Kura, John C Lang, Dawei Wang, et al.
Journal of Chromatography. A
|
March 17, 2015
Separation of therapeutic peptides with cyclofructan and glycopeptide based columns in hydrophilic interaction liquid chromatography
Yang Shu, John C Lang, Zachary S Breitbach, et al.
Epidemics
|
July 9, 2026
Clinical impact of childhood and adolescence dengue vaccination in Indonesia: A dynamic transmission modeling study
Salisu M Garba, Ibrahim Diakite, Yao-Hsuan Chen, et al.
Journal of Agricultural and Food Chemistry
|
February 9, 2016
Analysis of Long-Chain Unsaturated Fatty Acids by Ionic Liquid Gas Chromatography
Choyce A Weatherly, Ying Zhang, Jonathan P Smuts, et al.
Vaccines
|
June 27, 2025
Predicting the Epidemiological Effects in the United Kingdom of Moving from PCV13 to PCV15 in the Routine Pediatric 1 + 1 Vaccination Schedule
Rachel J Oidtman, Natalie Banniettis, Jessica Weaver, et al.
Expert Review of Vaccines
|
May 22, 2026
Epidemiological impact of a 20- or 21-valent pneumococcal conjugate vaccine in the Japan adult population: insights from a dynamic transmission model
Rachel J Oidtman, Atsushi Tajima, Taizo Matsuki, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
July 9, 2026
Health impact and cost-effectiveness analysis of introducing a national immunization program with 21-valent versus 20-valent pneumococcal conjugate vaccines for adults ≥ 65 years of age in Denmark
Oluwaseun Sharomi, Rachel J Oidtman, John C Lang, et al.
Journal of Preventive Medicine and Hygiene
|
April 20, 2026
Giovanna Elisa Calabrò, Caterina Rizzo, Vincenzo Baldo, et al.
Page
of 3